SYSFARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SYSFARMA
Largest movements
- Cash -€442,465
down €442,465 (-86.7%), from €510,396 to €67,932
mainly Contributions, distributions and other (-€511,820) and Smaller working-capital items (-€296)
- Tangible fixed assets -€18,422
down €18,422 (-2.8%), from €659,890 to €641,468
- Reserves -€462,738
down €462,738 (-40.4%), from €1.1m to €683,974
- Gross operating margin +€71,768
up €71,768 (+24,414%), from €294 to €72,062
- Taxes +€2,341
up €2,341 (+604%), from €388 to €2,729
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,171,722 | €711,122 | -€460,601 | -39.3% |
| Fixed assets | 21/28 | €659,890 | €641,468 | -€18,422 | -2.8% |
| Tangible fixed assets | 22/27 | €659,890 | €641,468 | -€18,422 | -2.8% |
| Land and buildings | 22 | €659,890 | €641,468 | -€18,422 | -2.8% |
| Current assets | 29/58 | €511,833 | €69,653 | -€442,179 | -86.4% |
| Amounts receivable within one year | 40/41 | €1,436 | €1,722 | +€286 | +19.9% |
| Other amounts receivable | 41 | €1,436 | €1,722 | +€286 | +19.9% |
| Cash at bank and in hand | 54/58 | €510,396 | €67,932 | -€442,465 | -86.7% |
| Total equity and liabilities | 10/49 | €1,171,722 | €711,122 | -€460,601 | -39.3% |
| Equity | 10/15 | €1,171,712 | €708,974 | -€462,738 | -39.5% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Reserves | 13 | €1,146,712 | €683,974 | -€462,738 | -40.4% |
| Distributable reserves | 133 | €1,146,712 | €683,974 | -€462,738 | -40.4% |
| Amounts payable | 17/49 | €10 | €2,147 | +€2,137 | +21,032% |
| Amounts payable within one year | 42/48 | €10 | €2,147 | +€2,137 | +21,032% |
| Taxes, remuneration and social security | 45 | - | €2,147 | +€2,147 | |
| Taxes | 450/3 | - | €2,147 | +€2,147 | |
| Other amounts payable | 47/48 | €10 | - | -€10 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18,422 | €18,422 | = | 0.0% |
| Other operating charges | 640/8 | €3,092 | €3,191 | +€99 | +3.2% |
| Gross operating margin | 9900 | €294 | €72,062 | +€71,768 | +24,414% |
| Operating profit (loss) | 9901 | -€21,220 | €50,450 | +€71,670 | |
| Financial income | 75/76B | €1,659 | €1,939 | +€280 | +16.9% |
| Recurring financial income | 75 | €1,659 | €1,939 | +€280 | +16.9% |
| Financial charges | 65/66B | €937 | €578 | -€359 | -38.3% |
| Recurring financial charges | 65 | €937 | €578 | -€359 | -38.3% |
| Profit (loss) for the period before taxes | 9903 | -€20,498 | €51,811 | +€72,309 | |
| Income taxes | 67/77 | €388 | €2,729 | +€2,341 | +604% |
| Profit (loss) for the period | 9904 | -€20,885 | €49,082 | +€69,968 | |
| Profit (loss) for the period to be appropriated | 9905 | -€20,885 | €49,082 | +€69,968 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.